Beyond safety: adverse events and unanticipated advantages of SGLT2 inhibitors
{{output}}
Background: Sodium-glucose transporter 2 inhibitors (SGLT2i) are widely used for diabetes management and have demonstrated benefits in treating acute and chronic heart failure (HF) and chronic kidney disease (CKD). Their increasi... ...
